跳至主要内容
临床试验/NCT00951561
NCT00951561已完成不适用

A Randomized Four-Way Crossover Comparison Study of Pain Relief From Dysmenorrhea Between the Vipon Tampon and Ibuprofen

Another Way Products2 个研究点 分布在 1 个国家目标入组 115 人开始时间: 2006年11月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
115
试验地点
2
主要终点
Percentage of Intervention Uses That Resulted in at Least 1 Point Decrease in Pain and Requiring no Rescue Medication Using the Modified Melzack-McGill Scale Using a Mixed Model

研究概览

简要总结

The purpose of this study is to compare the Vipon tampon with ibuprofen in relieving pain in women with dysmenorrhea. Subjects completed a total of 4 treatment intervals; each subject was randomized to use the VIPON as their treatment for two intervals and Ibuprofen as their treatment for two intervals.

详细描述

Pain caused by dysmenorrhea can range from mild to severe. At least 50% of all menstruating women experience appreciable pain at some time during their menstruation. An estimated 600 million work hours are lost annually to this affliction with an average loss of time of two or more workdays per year per female employee. Treatment of dysmenorrhea may include either non-pharmacological or pharmacological measures. Pharmacological treatments include oral contraceptives to treat hormonal imbalances, over-the-counter analgesics or non-steroidal anti-inflammatory drugs. The Vipon is a tampon with a small motor unit within, which produces vibratory stimulation. This study aims to provide information on the safety and efficacy of the Vipon in a randomized controlled clinical trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Females ages >= 18 years
  • 4 consecutive monthly menstrual cycles
  • Self-assessment of dysmenorrhea
  • Non-pregnant status
  • Agrees to use adequate birth control during the trial
  • Consents to use tampons through the test of cure assessment
  • Provides informed consent for participating in the trial

排除标准

  • Prohibited use of pain medication 4 hours prior to treatment and during the first 2 hours after treatment with study medication
  • Positive pregnancy test
  • Unwilling or unable to comply with protocol
  • Allergic to ibuprofen

研究组 & 干预措施

Vipon

Experimental

干预措施: Vipon (Device)

Ibuprofen

Active Comparator

干预措施: Ibuprofen (Drug)

结局指标

主要结局

Percentage of Intervention Uses That Resulted in at Least 1 Point Decrease in Pain and Requiring no Rescue Medication Using the Modified Melzack-McGill Scale Using a Mixed Model

时间窗: 1 month, 2 months, 3 months, 4 months

Modified Melzack-McGill Scale measures general pain (0=none, 1-3=mild, 4-6=moderate, 7-9=severe, 10=worst pain) Total Number of Uses Analyzed is a sum of the Number of Uses collected at each time point.

次要结局

未报告次要终点

研究者

发起方
Another Way Products
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验